---
schema_version: "secwatch.filing_event.v1"
accession: "0001615219-24-000076"
form_type: "8-K"
ticker: "DCOY"
cik: "0001615219"
company_name: "Decoy Therapeutics Inc."
filed_at: "2024-08-15T23:59:59+00:00"
generated_at: "2026-05-31T09:01:19.335436+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Salarius raises ~$1.5M to meet Nasdaq minimum equity requirement after being below $2.5M threshold

## Summary
- As of June 30, 2024, stockholders' equity was $2,375,353, below Nasdaq's $2.5M minimum.
- Sold 564,730 shares for gross proceeds of ~$1.5M via at-the-market offering to restore compliance.
- Company believes it now complies with Nasdaq Listing Rule 5550(b)(1) after the financing.
- Nasdaq will monitor; if next 10-Q shows non-compliance, common stock may be delisted.

## SEC filing metadata
- accession: 0001615219-24-000076
- form_type: 8-K
- ticker: DCOY
- cik: 0001615219
- company_name: Decoy Therapeutics Inc.
- filed_at: 2024-08-15T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1615219/000161521924000076/0001615219-24-000076-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1615219/000161521924000076/flks-20240813.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001615219-24-000076
- JSON: https://secwatch.observer/filing/0001615219-24-000076.json
- Plain text: https://secwatch.observer/filing/0001615219-24-000076.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.